A NEW RANGE OF PHARMACEUTICAL PRODUCTS NTC
CONTINUE READING >>
NTC Srl is a pharmaceutical company, specialized in the development of:
• Niche Generics
• Medical device
• Innovative food supplements
NTC Srl has in place various research&development agreements with some Italian universities and it holds several international patents.
NTC Srl holds a share percentage in an Italian Nanotech company.
NTC's main business activity is offering a globally exclusive portfolio of products to other pharmaceutical companies (B2B activity), as well
as directly to the consumer (B2C activity) in some selected markets.
NTC's international presence (either through licensors or distributors) covers more than 50 countries with products marketed or under registration.
NTC is pleased to announce its participation at CPHI Worldwide Frankfurt Messe, Germany.
Please visit us at NTC booth no. 40A11 Hall 4 at CPhI Worldwide - October 22nd-24th, 2013, Messe Frankfurt, Germany.
Active ingredient: AzelastinePresentation: 0,5mg/ml - 6ml eye drops bottleUse: local treatment of seasonal and perennial allergic conjunctivitisProduct profile: firstname.lastname@example.org
Albania - Algeria - Armenia - Australia - Austria - Azerbaijan - Bangladesh - Belgium - Belarus - Bosnia&Herzegovina - Burkina Faso - Bulgaria
Cambodia - Cameroon - Cyprus - Czech Republic - Denmark - Egypt - Estonia
Finland - France - Gabon - Georgia - Germany - Greece - Hong Kong - Hungary
Iceland - Indonesia - Iraq - Ireland - Israel, Italy - Jordan - Kazakhstan - Kenya - Kyrgyzstan - Kosovo
Latvia - Lebanon - Lithuania - Luxemburg - Macedonia - Malaysia - Moldova - Montenegro - Morocco - Myanmar
Nigeria - Norway - Pakistan - People's Republic of China - Philippines - Poland - Portugal
Romania - Russia - Saudi Arabia - Serbia - Singapore - Slovak Republic - Slovenia - South Africa - Spain - Sri Lanka - Sweden - Switzerland - Syria
Tajikistan - The Netherlands - Togo - Turchey - United Kingdom - Ukraine - Uzbekistan - Vietnam